WJCD  Vol.3 No.7 , October 2013
Tepid antegrade intermittent blood cardioplegia as an alternative for intermittent crossclamping with Lidoflazine
ABSTRACT
Background: Blood cardioplegia is a technique with many variations in its use. Intermittent cross clamping with Lidoflazine has proven to deliver good cardioprotection in our center. Question: Is tepid (32°C) antegrade intermittent blood cardioplegia an efficient, safe and easy-to-use alternative to intermittent cross-clamping with Lidoflazine in elective isolated CABG in low-risk patients? Primary outcomes are heart enzymes (cTnI, CK-MB). Secondary outcomes are operation times, length of hospital stay, major complications and in-hospital mortality. Methods: From January 2012 until November 2012, 40 patients with LVEF ≥50%, EuroSCORE II <3.5% and no severe systemic disease underwent elective CABG and were consecutively randomized to intermittent cross-clamping (ICC; n = 20) or blood cardioplegia (BCP; n = 20). All were operated on by the same surgeon. Results: There were no significant differences in age (BCP 65.34 ± 9.76; ICC 65.25 ± 8.42) and EuroSCORE II (BCP 1.25 ± 0.72; ICC 1.04 ± 0.71). There was a significant difference in cross clamp time (BCP 61.10 ± 23.07; ICC 41.30 ± 13.10). No significant differences in ECC-time (BCP 95.85 ± 27.04; ICC 113.80 ± 34.47) and number of distal anastomoses (BCP 2.70 ± 0.73; ICC 2.90 ± 0.72) were found. Values of cTnI 1-day postoperative (BCP 1.50 ± 0.76; ICC 4.50 ± 3.90), maximum cTnI (BCP 2.85 ± 1.73; ICC 6.40 ± 4.30) and maximum CK-MB (BCP 21.10 ± 22.30; ICC 31.35 ± 24.39) differed significantly. No significant differences in postoperative parameters were found: length of hospital stay (BCP 7.95 ± 1.40; ICC 8.25 ± 1.71), atrial fibrillation (BCP 0.20 ± 0.41; ICC 0.45 ± 0.51), major complications (BCP 0.35 ± 0.49; ICC 0.30 ± 0.47). There was no in-hospital mortality. Conclusion: Primary outcomes defined by the cardiac enzymes (cTnI, CK-MB) favour the use of tepid antegrade intermittent blood cardioplegia in low-risk patients undergoing elective CABG-operations. Regarding secondary outcomes, ICC showed shorter cross clamp times.

Cite this paper
Kalantary, S. , Bruyn, A. , Laga, S. and Rodrigus, I. (2013) Tepid antegrade intermittent blood cardioplegia as an alternative for intermittent crossclamping with Lidoflazine. World Journal of Cardiovascular Diseases, 3, 454-457. doi: 10.4236/wjcd.2013.37071.
References
[1]   Hendrikx, M., Jiang, H., Gutermann, H., Toelsie, J., Renard, D., Briers, A., Pauwels, J.L. and Mees, U. (1999) Release of cardiac troponin I in antegrade crystalloid versus cold blood cardioplegia. Journal of Thoracic and Cardiovascular Surgery, 118, 452-459.
http://dx.doi.org/10.1016/S0022-5223(99)70182-0

[2]   Pichon, H., Chocron, S., Alwan, K., Toubin, G., Kaili, D., Falcoz, P., Latini, L., Clement, F., Viel, J.F. and Etievent, J.P. (1997) Crystalloid versus cold blood cardioplegia and cardiac troponin I release. Circulation, 96, 316-320.

[3]   Elwatidy, A.M., Fadalah, M.A., Bukhari, E.A., Aljubair, K.A., Syed, A., Ashmeg, A.K. and Alfagih, M.R. (1999) Antegrade crystalloid cardioplegiavsantegrade/retrograde cold and tepid blood cardioplegia in CABG. Annals of Thoracic Surgery, 68, 447-453.
http://dx.doi.org/10.1016/S0003-4975(99)00359-8

[4]   Flameng, W. (1988) Myocardial protection. Annals of the New York Academy of Sciences, 522, 600-610.
http://dx.doi.org/10.1111/j.1749-6632.1988.tb33401.x

[5]   Flameng, W., Borgers, M., Van der Vusse, G.J., Demeyere, R., Vandermeersch, E., Thone, F., et al. (1983) Cardioprotective effects of lidoflazine in extensive aortacoronary bypass grafting. Journal of Thoracic and Cardiovascular Surgery, 85, 758-768.

[6]   Sadony, V., Korber, M., Albes, G., Podtschaske, V., Etgen, T., Trosken, T., et al. (1998) Cardiac troponin I plasma levels for diagnosis and quantitation of perioperative myocardial damage in patients undergoing coronary artery bypass surgery. European Journal of Cardio-Thoracic Surgery, 13, 57-65.
http://dx.doi.org/10.1016/S1010-7940(97)00304-7

[7]   Costa, M.A., Carere, R.G., Lichtenstein, S.V., Foley, D.P., de Valk, V., Lindenboom, W., et al. (2001) Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS). Circulation, 104, 2689-2693.
http://dx.doi.org/10.1161/hc4701.099789

[8]   Martin, J. and Benk, C. (2006) Blood Cardioplegia. Multimedia Manual of Cardiothoracic Surgery, 1009, 1510.
http://dx.doi.org/10.1510/mmcts.2004.000745

[9]   Boethig, D., Minami, K., Lueth, J.U., El-Banayosy, A., Breymann, T. and Koerfer, R. (2004) Intermittent aortic cross-clamping for isolated CABG can save lives and money: Experience with 15307 patients. Thoracic and Cardiovascular Surgeon, 52, 147-151.
http://dx.doi.org/10.1055/s-2004-817979

[10]   He, G.W. and Yang, C.Q. (1996) Hyperkalemia alters endothelium-dependent relaxation through non-nitric oxide and noncy-clooxygenase pathway: A mechanism for coronary dysfunction due to cardioplegia. Annals of Thoracic Surgery, 61, 1394-1399.
http://dx.doi.org/10.1016/0003-4975(96)00086-0

 
 
Top